News Image

Thursday's pre-market session: top gainers and losers

By Mill Chart

Last update: May 9, 2024

Curious about the stocks that are showing activity before the opening bell on Thursday?

Today's pre-market gainers

TickerChangeComment
IVP35.26%During Thursday's pre-market trading, INSPIRE VETERINARY PARTNE-A (NASDAQ:IVP) demonstrated strong momentum, with the stock price rising 35.26% to $4.91. Continuing its strong performance from the previous session, NASDAQ:IVP experienced a significant 10.0K% gain, setting a positive tone for today's pre-market session.
AIXI29.37%During Thursday's pre-market session, XIAO I CORP (NASDAQ:AIXI) experienced a 29.37% increase, with the stock price reaching $1.63. In the last month the stock lost 29.61%.
BENFW25.2%BENEFICIENT CO GROUP -28's (NASDAQ:BENFW) shares surged 25.2% to reach $0.02 during the pre-market session on Thursday. The stock is trading 48.19% higher than a month ago.
ICUCW21.65%LMF ACQUISITION OPP -A -CW26's (NASDAQ:ICUCW) stock price is advancing with 21.65% to a price of $0.09. The stock is trading 41.97% lower than a month ago.
ZLAB20.7%ZAI LAB LTD-ADR's (NASDAQ:ZLAB) stock price is advancing with 20.7% to a price of $20.0. A press release (Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates) was released yesterday.
ZIMV20.29%ZIMVIE INC's (NASDAQ:ZIMV) shares surged 20.29% to reach $18.5 during the pre-market session on Thursday. Yesterday the company had a press release: ZimVie Reports First Quarter 2024 Financial Results.
NOTE16.39%FISCALNOTE HOLDINGS INC's (NYSE:NOTE) stock price increased by 16.39% to $1.42. The company's earnings where released Yesterday. A press release (FiscalNote Reports First Quarter 2024 Financial Results) was released earlier today.
GWAV16.35%GREENWAVE TECHNOLOGY SOLUTIO's (NASDAQ:GWAV) shares rose 16.35% to $0.07. In the last month the stock lost 56.9%.
GLMD15.71%Pre-market trading on Thursday showed positive momentum for GALMED PHARMACEUTICALS LTD (NASDAQ:GLMD), as the stock price advanced 15.71% to reach $0.45. Shareholders saw the stock price going 92.2% lower is the past year.
WAVD14.29%During Thursday's pre-market trading, WAVEDANCER INC (NASDAQ:WAVD) demonstrated strong momentum, with the stock price rising 14.29% to $3.6. The positive trend witnessed yesterday with a 30.17% gain persists in today's pre-market, indicating sustained growth for NASDAQ:WAVD.

For the full premarket gainers list go to our premarket gainers page.

Pre-market losers

TickerChangeComment
EMKR-39.71%During Thursday's pre-market session, the shares of EMCORE CORP (NASDAQ:EMKR) declined by 39.71%, reaching $1.75. In the last 3 months the share price dropped with 24.08%.
TIVC-36.57%During Thursday's pre-market session, the shares of TIVIC HEALTH SYSTEMS INC (NASDAQ:TIVC) declined by 36.57%, reaching $0.85. Despite a promising gain of 27.62% yesterday, NASDAQ:TIVC faces downward pressure with a 36.57% decline in today's pre-market session. Yesterday the company had a press release: Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems.
FWRD-30.26%Thursday's pre-market session showed a 30.26% decrease in the stock price of FORWARD AIR CORP (NASDAQ:FWRD), reaching $15.0. Yesterday the company had a press release: Forward Air Corporation Reports First Quarter 2024 Results.
CTMX-28.4%Today's pre-market session reveals a 28.4% decline in the stock price of CYTOMX THERAPEUTICS INC (NASDAQ:CTMX), now priced at $3.0. Shareholders saw the stock price going 99.52% higher in the past month.
RBLX-28.39%Investors observed a 28.39% decline in ROBLOX CORP -CLASS A's (NYSE:RBLX) stock price, which now stands at $27.95 during Thursday's pre-market session. ROBLOX CORP -CLASS A released earnings Yesterday. Earlier today the company had a press release: Roblox Reports First Quarter 2024 Financial Results.
CDLX-28.36%Investors observed a 28.36% decline in CARDLYTICS INC's (NASDAQ:CDLX) stock price, which now stands at $10.46 during Thursday's pre-market session. Yesterday the company had a press release: Cardlytics Announces First Quarter 2024 Financial Results.
SYRA-20.09%SYRA HEALTH CORP - CLASS A's (NASDAQ:SYRA) shares fell 20.09% to $1.71. The current market conditions exhibit high volatility as NASDAQ:SYRA retraces its steps after yesterday's 42.67% gain.
EPAM-17.64%EPAM SYSTEMS INC's (NYSE:EPAM) stock price decreased by 17.64% to $205.25. The company's earnings where released Yesterday.
CRNC-17.36%CERENCE INC's (NASDAQ:CRNC) stock price is declining with 17.36% to a price of $7.9. CERENCE INC released earnings Yesterday. The stock is trading 27.25% lower than a month ago.
ISUN-17.12%ISUN INC's (NASDAQ:ISUN) shares fell 17.12% to $0.17. After yesterdays gain of 51.36%, it goes down with 17.12% in today's pre-market session.

Our premarket losers page will show you the full list.

Back

CYTOMX THERAPEUTICS INC

NASDAQ:CTMX (5/30/2024, 7:00:01 PM)

After market: 1.7403 -0.01 (-0.55%)

1.75

0 (0%)

CTMX News

News Image2 days ago - InvestorPlaceNo Memes, Ma’am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.

It's time to take CytomX Therapeutics stock seriously as CytomX Therapeutics forges a crucial partnership with a pharmaceutical powerhouse.

News Image8 days ago - CytomX Therapeutics Inc.CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally...

News Image14 days ago - CytomX Therapeutics Inc.CytomX Therapeutics Announces New Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally...

News Image15 days ago - USA News GroupBiotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/PRNewswire/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood...

News Image15 days ago - USA News GroupBiotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

News Image21 days ago - InvestorPlaceSOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity

SoundHound AI stock is slipping on Thursday as SOUN investors appear unimpressed by a new LLM collaboration with Perplexity.

News Image21 days ago - InvestorPlaceDear NVDA Stock Fans, Mark Your Calendars for June 2

Nvidia stock fans will want to keep an eye on the tech company when June 2 rolls around for a potential catalyst for NVDA shares.

News Image21 days ago - InvestorPlaceWhy Is CytomX (CTMX) Stock Down 43% Today?

CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update.

News Image22 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!

News Image22 days ago - InvestorPlaceCTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024

CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image22 days ago - BusinessInsiderCTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CytomX Therapeutics (NASDAQ:CTMX) just reported results for the first quarter o...

News Image22 days ago - CytomX Therapeutics Inc.CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

- CX-904 demonstrated a favorable safety profile with no cytokine release syndrome (CRS) of any grade observed in step-dosing cohorts and no grade >1...

CTMX Links
Follow us for more